Wilson Sonsini Goodrich & Rosati has advised Solve Therapeutics. Solve Therapeutics, a clinical-stage biotechnology company, has secured $120 million in an oversubscribed and upsized financing round...
Wilson Sonsini Goodrich & Rosati has advised Solve Therapeutics. Solve Therapeutics, a clinical-stage biotechnology company, has secured $120 million in an oversubscribed and upsized financing round...
